Coiled coils are a major motif in proteins and orchestrate multimerization of various complexes important for biological processes. Inhibition of coiled coil-mediated interactions has significant biomedical potential. However, general approaches that afford short peptides with defined coiled coil conformation remain elusive. We evaluated several strategies to stabilize minimal helical bundles, with the dimer motif as the initial focus. A stable dimeric scaffold was realized in a synthetic sequence by replacing an interhelical ionic bond with a covalent bond. Application of this strategy to a more challenging native protein-protein interaction (PPI) suggested that an additional constraint, a disulfide bond at the internal a/d' position along with a linker at the e/e' position, is required for enhanced conformational stability. We anticipate the coiled coil stabilization methodology described herein to yield new classes of modulators for PPIs.
Coiled coils are a major motif in proteins and orchestrate multimerization of various complexes important for biological processes. Inhibition of coiled coil-mediated interactions has significant biomedical potential. However, general approaches that afford short peptides with defined coiled coil conformation remain elusive. We evaluated several strategies to stabilize minimal helical bundles, with the dimer motif as the initial focus. A stable dimeric scaffold was realized in a synthetic sequence by replacing an interhelical ionic bond with a covalent bond. Application of this strategy to a more challenging native protein-protein interaction (PPI) suggested that an additional constraint, a disulfide bond at the internal a/d' position along with a linker at the e/e' position, is required for enhanced conformational stability. We anticipate the coiled coil stabilization methodology described herein to yield new classes of modulators for PPIs.
Mimicry of critical secondary
structure motifs that mediate protein–protein interactions
(PPIs) offers a promising approach for the discovery of new classes
of therapeutics.[1] Several inhibitors of
helical protein interfaces have been described, owing to the
high occurrence of helices at PPI interfaces[3] and the development of synthetic approaches that enabled
mimicry of this secondary structure.[5] Examination
of PPI interfaces suggests that many complexes often utilize
contacts from multiple helices, and that these complexes will potentially
require inhibitors that are capable of interactions beyond mimicry
of a single helix.[8] These multi-helix interfaces
commonly comprise individual helices from the α-helical coiled
coil motif.[10] An example of such an interface
is shown in Figure , where a protein partner presents critical residues for biomolecular
recognition from helices that are part of two-strand coiled coil assemblies.
We have undertaken a comprehensive analysis of high-resolution structures
in the Protein Data Bank to identify all PPIs mediated by helix dimers.[8]
Figure 1
An example of a protein complex that utilizes residues
from both
helices of a dimeric coiled coil domain to target the partner proteins.
Model depicts complex between IL-4 and IL-4 receptor α-chain
(PDB code 1IAR).
An example of a protein complex that utilizes residues
from both
helices of a dimeric coiled coil domain to target the partner proteins.
Model depicts complex between IL-4 and IL-4 receptor α-chain
(PDB code 1IAR).Formation of coiled coil assemblies
is implicated in many biological
processes. Canonical coiled coils are stabilized by a series of hydrophobic
knobs-into-holes[10] packing interactions
along with inter- and intrastrand electrostatic contacts.[11−13] Several helical peptides and peptidomimetic inhibitors that
target coiled coil domain assembly in biological processes such as
viral fusion have been described.[14] These
inhibitors function by inhibiting formation of coiled coil contacts.
This strategy may also be applicable to complexes between globular
proteins and pre-formed coiled coils, such as the one depicted in Figure . An alternative
strategy could be to utilize coiled coil mimics or stable helix dimers
that display the desired functionality to interact with the
globular protein partner.Our survey of the structural data
reveals that typical helical
dimers in PPIs span 12–18 residues per helix,[8] which is consistent with the average length of helices
at protein interfaces.[3] A suitable
dimeric helix scaffold would thus be capable of spanning this length.
The stability of coiled coils, however, is directly proportional to
the number of heptad repeats and the correct pairing of the hydrophobic
and ionic residues. Coiled coils consisting of less than three heptads
are generally not stable.[19] Although highly
engineered short coiled coils have been described,[13,20,21] these approaches may not be suitable for
inhibitor design as at least one face of the dimer is needed to display
appropriate functionality to engage the target. We envisioned a synthetic
approach that could be applied to stabilize a range of helical dimers
in a sequence-independent manner.Coiled coils
consist of heptad repeats with critical hydrophobic
contacts at the a and d positions
and ionic residues at the e and g positions. We hypothesized that a helix capable of a minimum of
three a/d hydrophobic contacts
(or 1.5 heptads) provides a reasonable starting point for development
of minimal coiled coil mimics. We postulated that strategies that
stabilize such short helix dimers would also be applicable for longer
chains since coiled coil stability increases with number of contacts.[19] Short, helical dimers can project side chains
for biomolecular recognition only if individual helices are
packed against each other.[10] We envisioned
four different approaches for the de novo design
of minimal coiled coil mimics for the stabilization of a model sequence
(Figure ). The model
sequence incorporates favorable hydrophobic residues at a/d positions as well as judicioulsly placed
inter- and intrastrand ionic interactions to enhance both
the helix and the dimer stability. We created a hydrophobic
interface following the recently described design rules for
vertical triads.[22] Gellman and Woolfson
et al. suggest that placement of Leu-Ile-Leu residues at a-a′-a positions contributes significantly to
helical dimer stability because of optimal packing interactions.[22] We positioned intra- and interhelical
salt bridges at appropriate positions to enhance stability of coiled
coil assemblies.[12,13,23] These design considerations led to peptides A (Ac-ELAELEWRL-NH2) and B (Ac-LWERIARLR-NH2). Potential inter- and intrastrand interactions between A and B in the context of an antiparallel coiled
coil are depicted in Figure a.
Figure 2
Strategies to template coiled coil formation of designed peptides.
(a) A potential antiparallel coiled coil assembly between peptides A and B. (b) Use of H-bond surrogate helices
to stabilize helical dimers, (c) macrocyclization of peptides, (d)
use of interhelical disulfide bridges in place of hydrophobic
contacts to aid assembly, and (e) placement of covalent bonds in place
of interstrand ionic interactions.
Strategies to template coiled coil formation of designed peptides.
(a) A potential antiparallel coiled coil assembly between peptides A and B. (b) Use of H-bond surrogate helices
to stabilize helical dimers, (c) macrocyclization of peptides, (d)
use of interhelical disulfide bridges in place of hydrophobic
contacts to aid assembly, and (e) placement of covalent bonds in place
of interstrand ionic interactions.Seminal work investigating the stabilities of minimal, de novo-designed coiled coils suggests that our designed
peptides (A and B) would not spontaneously
assemble in aqueous solution,[19] because
(a) short peptides do not adopt stable helical conformations[24] and (b) short helices do not create enough contacts
to favor dimer assembly. Circular dichroism (CD) spectroscopy was
used to assess the conformational stability of peptides. CD provides
a distinct signature for α-helices with a maximum near 190 nm
and minima at 208 and 222 nm.[26] The relative
helicity of peptides is typically estimated by the mean residue ellipticity
at 222 nm,[26,27] although these estimates are
often not accurate for short helices.[28] The ratio of the 222/208 nm bands offers an additional gauge of
α-helicity. The origin and effect of peptide sequence on this
ratio remain ill-defined,[26] but a ratio
of ≥1 is expected of stable α-helices.[31] CD results displayed nonhelical signatures for each individual
peptide (A and B) and their equimolar mixture
at 20 μM concentration (Supporting Information (SI), Figure S1).We evaluated the potential of four
synthetic strategies to create
conformationally defined coiled coil mimics (Figure ). The minimal mimetic designs build on the
following key hypotheses: (a) Stabilization of individual helices
will enhance stability of the dimeric assembly, and coil formation
in an attached peptide can be nucleated with a preformed helix.[32] (b) Macrocyclization of the dimeric scaffold
would aid interpeptide contacts and helix formation.[32] (c) Noncovalent interhelical contacts
can be strengthened by substitution with covalent bonds.[35] Our studies reveal that replacement of an interhelical
ionic bond with a covalent bond provides a general and versatile approach
for stabilization of short helix dimers. We extensively characterized
the constrained, antiparallel coiled coil mimics by CD and 2D
NMR spectroscopies and then applied the design to the modulation of
a PPI involved in leukemogenesis, where complex formation depends
on coiled coil assembly.We began by determining if a preformed
helix could nucleate helical
conformation in an attached peptide. We utilized the H-bond surrogate
(HBS)[35] strategy to stabilize the helical
conformation in peptide A, and installed a GGSSGG
linker[22] between HBS-A helix
and peptide B to access AB-1 as a potential
antiparallel helix-loop-helix motif. However, CD studies indicated
a weakly helical signature in AB-1 reminiscent of a single
short helix stabilized by the HBS approach (Figure S1).We next tested whether macrocycliclization of peptides
A and B
with two GGSSGG loops (AB-2: cyclo(GGSSGGELAELEWRLGGSNGGLAERIARLR)
could induce helical dimer association in both sequences (Figure b). This scaffold
would potentially limit fraying at all four peptide termini while
promoting interstrand hydrophobic interactions.
Again, CD spectroscopy revealed minimal helicity, suggesting that
macrocyclization did not lead to a significant conformational stability
relative to the HBS strategy (Figure S1). Subsequently, we sought to determine if an interhelical
disulfide linkage in place of hydrophobic pairing would lead
to a stable dimer. Hodges et al. demonstrated that mutation of hydrophobic
residues to create disulfide bridges increases coiled coil stability
while preserving coiled coil structure.[36] Their seminal work serves as the basis of our disulfide design.
We synthesized a bis-cysteine peptide (AB-3: ECAELEWRLGGSSGGLAERIARCR)
on resin followed by disulfide formation and characterized its helical
content by CD. Analysis revealed that this approach also did not provide
significant helical stabilization in short sequences.Salt-bridge
networks contribute significantly to coiled coil chain
alignment as well as to general helix stability;[13,38] although there is debate,[40] individual
salt-bridges are thought to stabilize helices and coiled coils by
≤0.5 kcal/mol.[42] We envisioned that
replacement of a weak interhelical ionic bond at g/g′ or e/e′ positions with a covalent bond would offer an attractive
option for stabilizing helical dimers. Although many covalent constraints
can be envisioned, in this preliminary investigation, we designed
bis-triazole linkers formed via copper-catalyzed azide–alkyne
cycloaddition reaction to constrain peptides A and B (Figure ).[32,47] Bis-triazole bridges of varying lengths
resulting from azidoalanine, azidohomoalanine, and
azidolysine residues were incorporated at positions e/e′ to obtain dimers AB-4, AB-5, and AB-6, respectively (Figure a). The azido side
chains were reacted with propargyl ether to obtain the bis-triazole
linkers. Solid-phase synthesis of AB-4–AB-6 is described in Figure S2. CD analysis
reveals that replacement of an ionic bond with a covalent linkage
has a dramatic effect on the conformational stability in a linker-length-dependent
manner (Figure b).
Based on the intensity of the 222 nm minimum and 222/208 nm ratio,
we find AB-4 and AB-5 constructs derived
from azidolysine and azidohomoalanine, respectively,
to be significantly more helical than AB-6.
Figure 3
(a) Design
of cross-linked helix dimers by replacement of an interstrand
ionic contact with bis-triazole linkers. Bis-triazole linkers of varying
lengths resulting from azidoalanine, azidohomoalanine,
and azidolysine residues were incorporated at coiled coil positions e/e′ to obtain dimers AB-4, AB-5, and AB-6, respectively. (b) CD
spectra of AB-4–AB-6 in 50 mM aqueous
KF, pH 7.4. (c) Helical wheel diagram of AB-4. (d) NMR-derived
structure of AB-4. The lowest conformer (top) and ensemble
of 20 lowest conformers (bottom).
(a) Design
of cross-linked helix dimers by replacement of an interstrand
ionic contact with bis-triazole linkers. Bis-triazole linkers of varying
lengths resulting from azidoalanine, azidohomoalanine,
and azidolysine residues were incorporated at coiled coil positions e/e′ to obtain dimers AB-4, AB-5, and AB-6, respectively. (b) CD
spectra of AB-4–AB-6 in 50 mM aqueous
KF, pH 7.4. (c) Helical wheel diagram of AB-4. (d) NMR-derived
structure of AB-4. The lowest conformer (top) and ensemble
of 20 lowest conformers (bottom).The conformational stability of the cross-linked helix dimer
(CHD) AB-4 (Figure c) was further assessed using a combination of 1D NMR,
total correlation
spectroscopy (TOCSY), and nuclear Overhauser effect spectroscopy (NOESY)
in 10% d3-CH3CN in H2O with 0.1% TFA (pH 5). We found addition of 10% acetonitrile to
be necessary to limit aggregation of the peptide at the 0.5 mM concentration
needed for NMR. The NOESY spectrum revealed NOE crosspeaks indicative
of a helical tertiary structure, showing sequential dNN (i,i+1) and several medium range
NOEs (dαN (i,i+3)) suggestive of stable helices (SI, Figure S3). Additionally, the backbone dihedral angles (Φ) calculated
from 3JNHCHα coupling
constants fall in the range expected for canonical α-helices.
A structural model of AB-4 was calculated using 65 NOESY
crosspeaks and 18 Φ constraints (Figure d).To establish that the CHD strategy
can be translated from a designed
sequence to a native protein coiled coil, we developed mimics of Nervy
homology two (NHR2) domain of the AML1-ETO-containing transcription
factor complex which interacts with NHR2-binding (N2B) motif
of E-proteins.[51] This complex is critical
for leukemogenesis and features a dimeric, antiparallel coiled
coil from NHR2 at the interface to engage N2B (Figure a). Computational alanine scanning
(SI, Table S1) and experimental mutagenesis
data[51] reveal residues E501, H504, L508,
V522, and S525 as keys for binding.
Figure 4
(a) Model depicting binding of NHR2 (gray)
to N2B (magenta) with
critical residues labeled. PDB code: 4JOL (b) Helical wheel diagrams depicting
sequences for the native (CHD-NHR2-1) and the redesigned
(CHD-NHR2-2) sequences. Z = azidolysine-derived
bis-triazole linker. (c) CD spectra of CHD-NHR2-1, CHD-NHR2-2, and CHD-NHR2-3 in 50 mM aqueous KF, pH 7.4. (d) Computational
model and helical wheel diagram of CHD-NHR2-3.
(a) Model depicting binding of NHR2 (gray)
to N2B (magenta) with
critical residues labeled. PDB code: 4JOL (b) Helical wheel diagrams depicting
sequences for the native (CHD-NHR2-1) and the redesigned
(CHD-NHR2-2) sequences. Z = azidolysine-derived
bis-triazole linker. (c) CD spectra of CHD-NHR2-1, CHD-NHR2-2, and CHD-NHR2-3 in 50 mM aqueous KF, pH 7.4. (d) Computational
model and helical wheel diagram of CHD-NHR2-3.To investigate the potential of a bis-triazole bridge to
induce
stable, dimeric helical conformation in an NHR2 sequence, we inserted
azidolysine residues at the e/e′
position of the native sequence to obtain CHD-NHR2-1: EWKHLZHLLN/ELWRSIRVLZ (Figure b). CD spectroscopy showed this construct
to be largely nonhelical (Figure c). We attribute this result to the missing stabilizing
contribution from the hydrophobic vertical triad, since the
native sequence contains potentially disruptive large tryptophan and
polar thereonine within the interior of its hydrophobic core.[52] The native sequence also contains two positively
charged residues near the amino terminus, which likely reduce the
helical stability. We redesigned CHD-NHR2-1 to include
the optimal hydrophobic residues from AB-4 and
intrahelical salt-bridges at the i and i+3 positions while preserving the native residues that
interact with N2B to obtain CHD-NHR2-2: ELWHLZELLR/ELWRSIRVLZ. The redesigned sequence is significantly more helical than the
parent, as ascertained by the intensity of the 222 nm minimum and
the ratio of the 222/208 nm bands (Figure c), but the overall helical stability of
this native sequence remained low (θ222 < 10 000)
as compared to the designed sequence AB-4 (θ222 = 14 000). This result prompted us to reevaluate
our stabilization approach to determine if further constraints can
be placed to stabilize the dimer in the context of difficult biological
sequences. Placement of more than one linker at the g/g′ position is not desirable as it would
influence the binding surface. Although the internal disulfide bridge
did not offer significant stability in the context of a flexible tether
(AB-3), we sought to determine the effect of interhelical
disulfide bonds in enhancing stability of triazolecross-linked dimer CHD-NHR2-2.Disulfide bridges may be placed at different a/d positions within CHD-NHR2-2 such
that they are located adjacent to the triazole link at e/e′ positions or farther away (Figure d and SI, Figure S4). We conjectured that placement of the disulfide
bond farthest away from the triazole bridge would have the highest
impact on helix stability as the designed salt bridge surrogate may
not be an optimal helix nucleator.[35] Our
results support this hypothesis. CHD-NHR2-3 in which the disulfide is located distal
from the triazole bridge is significantly more helical, according
to CD spectroscopy, than CHD-NHR2-4 and CHD-NHR2-5, where the disulfide bonds are placed near the
triazole linker (Figure S4). CHD-NHR2-3 is also significantly
more helical than CHD-NHR2-2, with the overall CD signature
similar in intensity to that of AB-4 (Figure c).Next, we determined
the binding affinities of the designed NHR2
mimetics to correlate their molecular recognition attributes with
the conformational stability. We utilized a previously described fluorescence
polarization assay with a fluorescein-labeled N2B peptide to evaluate
binding of the cross-linked dimers as compared to the native NHR2
coiled coil (NHR2482–551).[51] The native NHR2 domain binds to the N2B peptide in agreement with
published results (Kd = 356 ± 90
μM), while CHD-NHR2-1, CHD-NHR2-2,
and CHD-NHR2-3 target N2B with Kd values of >10 000,
236 ± 90, and 53 ± 20 μM respectively, highlighting
the influence of conformational stability on molecular recognition.
As expected, the doubly cross-linked dimer, with higher conformational
stability, binds to the target with the highest affinity. The 5-fold
enhanced affinity of the much shorter CHD-NHR2-3 (20 residues) mimetic versus the native
NHR2 coiled coil (138 residues) is notable and supports our design
principles.Lastly, we investigated if contacts from both helices
are required
for binding to N2B peptide, i.e., if the dimeric construct is necessary
for interacting with the target peptide. Residues S522 and V525
on one helix strand and E501 and L508 on the opposite strand are suggested
to be critical for binding. CHD-NHR2-6 (S522A/V525A)
and CHD-NHR2-7 (E501A/L508A) were designed as
controls for CHD-NHR2-2 and contain alanine mutations
on one strand per dimer while retaining a CHD-NHR2-2 sequence
on the other strand (Table ). Both control constructs bound N2B with diminished affinity
(Kd > 3000 μM), supporting the
requirement
of critical residues on each helical strand and our hypothesis that
a dimer is needed to engage such PPIs.
Table 1
Sequences
and Binding Affinities of
the Native NHR2 Coiled Coil and the Cross-Linked Helix
Dimer (CHD) Mimics
compound
sequencea
Kd (μM)b
NHR2
GST-NHR2(482–551)
356 ± 90
CHD-NHR2-1
EWKHLZHLLN/KTRRSLTVLZ
>10 000
CHD-NHR2-2
ELWHLZELLR/ELWRSIRVLZ
236 ± 90c
CHDDS-NHR2-3
ELWHLZELCR/ECWRSIRVLZ
53 ± 20
CHD-NHR2-6
ALWHLZEALR/ELWRSIRVLZ
>3000
CHD-NHR2-7
ELWHLZELLR/ELWRAIRALZ
>3000
Z = azidolysine-derived bis-triazole
linker; alanine mutations are underlined.
Binding affinity calculated using
a fluorescence polarization assay with fluorescein-labeled N2B peptide
(SI, Figure S12).
CHD-NHR2-2 is not fully
soluble at >1 mM concentrations, leading to a noisy upper bound
and
nonoptimal curve fit.
Z = azidolysine-derived bis-triazole
linker; alanine mutations are underlined.Binding affinity calculated using
a fluorescence polarization assay with fluorescein-labeled N2B peptide
(SI, Figure S12).CHD-NHR2-2 is not fully
soluble at >1 mM concentrations, leading to a noisy upper bound
and
nonoptimal curve fit.In
summary, we have investigated various stabilization strategies
to design minimal mimics of helical tertiary structures. Our studies
reveal that judicious replacement of interhelical ionic contacts
with covalent linkages and substitution of internal hydrophobic
interactions with disulfide bonds afford stable dimeric helical
conformations in difficult biological sequences. We applied the design
principles to the stabilization of short sequences from a biological
assembly to evaluate the potential of the minimal mimetics to reproduce
native binding interactions of much longer protein coiled coils.
Given the ubiquity of helical PPIs,[8] we
anticipate that the helix tertiary structure mimics will prove to
be useful as inhibitors.
Authors: J M Kilby; S Hopkins; T M Venetta; B DiMassimo; G A Cloud; J Y Lee; L Alldredge; E Hunter; D Lambert; D Bolognesi; T Matthews; M R Johnson; M A Nowak; G M Shaw; M S Saag Journal: Nat Med Date: 1998-11 Impact factor: 53.440
Authors: Bobo Dang; Haifan Wu; Vikram Khipple Mulligan; Marco Mravic; Yibing Wu; Thomas Lemmin; Alexander Ford; Daniel-Adriano Silva; David Baker; William F DeGrado Journal: Proc Natl Acad Sci U S A Date: 2017-09-25 Impact factor: 11.205
Authors: Bryan P Sutherland; Bassil M El-Zaatari; Nicole I Halaszynski; Jonathan M French; Shi Bai; Christopher J Kloxin Journal: Bioconjug Chem Date: 2018-11-26 Impact factor: 4.774